ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 256 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $86 | +16.2% | 201 | +7.5% | 0.00% | – |
Q1 2024 | $74 | +1.4% | 187 | -3.1% | 0.00% | – |
Q4 2023 | $73 | -28.4% | 193 | -6.8% | 0.00% | -100.0% |
Q3 2023 | $102 | +64.5% | 207 | +29.4% | 0.00% | – |
Q2 2023 | $62 | +14.8% | 160 | +10.3% | 0.00% | – |
Q1 2023 | $54 | -22.9% | 145 | -21.2% | 0.00% | -100.0% |
Q4 2022 | $70 | -99.9% | 184 | +13.6% | 0.00% | – |
Q3 2022 | $57,000 | +32.6% | 162 | +42.1% | 0.00% | – |
Q2 2022 | $43,000 | +152.9% | 114 | +107.3% | 0.00% | – |
Q1 2022 | $17,000 | +41.7% | 55 | +66.7% | 0.00% | – |
Q4 2021 | $12,000 | +500.0% | 33 | +450.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | – | 6 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |